Exhibiting at VIV Asia 2025

Novation 2002 S.L. is a Spain-based biotechnology company that specializes in innovative solutions for animal nutrition, particularly focused on gut health and feed efficiency. Established with a vision to revolutionize livestock productivity through scientifically backed feed additives, Novation 2002 has positioned itself as a pioneer in the use of protected butyric acid in animal feed, setting industry standards through their flagship product, Butirex C4.

Core Business and Specialization

At the heart of Novation 2002’s operations lies the development and commercialization of feed additives designed to enhance the digestive health and performance of livestock. The company's primary focus areas include:

• Protected Sodium Butyrate formulations for gut health
• Solutions aimed at reducing antibiotic dependency in animal husbandry
• Promoting natural growth and immunity in monogastric animals

Its patented technology in the formulation of Butirex C4, a protected form of sodium butyrate, is backed by multiple peer-reviewed studies and commercial trials showing improved animal performance and intestinal integrity. The product uses Matrix Coating Technology to ensure optimal release throughout the gastrointestinal tract.

Product Portfolio

Novation 2002’s flagship product is:

• Butirex C4 – Protected sodium butyrate feed additive designed for pigs and poultry, which supports gut health, reduces inflammation, and enhances feed conversion.

Other offerings include tailored feed additive solutions for:

• Poultry
• Swine
• Calves and Ruminants

Their approach blends biotechnology, veterinary science, and precision nutrition to address specific animal health challenges.

Certifications and Compliance

Novation 2002 adheres to stringent EU feed additive regulations, and their production process is ISO-certified to ensure quality and safety. The company operates in compliance with:

• FAMI-QS (Feed Additive and PreMixture Quality System)
• GMP+ (Good Manufacturing Practices)
• ISO 22000 for food safety management

These certifications reinforce the brand’s commitment to transparency and product efficacy in the global feed industry.

Market Presence and Target Geography

With a manufacturing base in Spain, Novation 2002 has established a strong export-oriented business model. Its products are present in over 40 countries, spanning Europe, Latin America, Asia, and the Middle East. Key markets include:

• Spain
• Brazil
• Vietnam
• Thailand
• Egypt
• Mexico
• India

The company collaborates with global distributors and technical teams to offer localized solutions and customer support.

Financials and Shipment Data

While Novation 2002 S.L. is a privately held company and does not disclose full financials publicly, data from third-party trade intelligence platforms like Volza and ImportYeti indicate a robust export record:

• Over 180 international shipments in the past 24 months
• Major export destinations: Brazil, Vietnam, and Thailand
• Primary product: Butirex C4 in various formulations

This performance underscores the company’s strength in international markets and its reputation for consistent product quality.

Capabilities and R&D

Novation 2002 maintains an in-house R&D division that collaborates with universities and research centers in Spain and across Europe. Their innovation is grounded in:

• Animal performance trials
• Microbiota research
• Controlled-release additive technologies

They invest significantly in clinical validation, ensuring all products are backed by scientific data, enhancing both customer trust and market credibility.

Customer Testimonials and Industry Recognition

Industry professionals have consistently recognized Butirex C4 for its efficacy. According to trials published in veterinary journals:

• Pigs supplemented with Butirex C4 showed a 7–10% increase in feed conversion efficiency
• Poultry trials revealed improved gut morphology and a reduction in pathogenic bacteria

Distributors and veterinary nutritionists have cited the product’s consistency, safety, and adaptability across species as key differentiators.

Achievements

• Pioneered the commercialization of matrix-coated sodium butyrate in Spain
• Exported to more than 40 countries, expanding across four continents
• Conducted over 50 peer-reviewed trials and technical validations
• Featured in industry expos such as VIV Europe, EuroTier, and IPPE Atlanta

Novation 2002’s strategic mix of R&D strength, regulatory compliance, and a proven track record of global exports firmly positions it as a trusted partner in animal nutrition solutions. Their commitment to gut health through science continues to support the sustainable transformation of animal farming practices worldwide.